**Doctor Convicted in $45 Million Botox Fraud Scheme**
:max_bytes(150000):strip_icc():format(jpeg)/Dr-Violetta-Mailyan-DO-MS-052226-5641ee9c65c344ef9aef9da223d37482.jpg)
A physician from Glendale, California, has been convicted of orchestrating a fraud scheme amounting to $45 million, involving false claims of Botox treatments. Violetta Mailyan, aged 45, was found guilty of multiple counts of wire fraud and obstruction of a criminal investigation, according to the U.S. Department of Justice.
In a jury trial held in the Central District of California, Mailyan was convicted on May 18 after evidence revealed that while she was on holidays, she submitted fraudulent claims for Botox treatments. The jury found that many of these treatments were billed for patients who either never received them or for those who did not require them medically.

Mailyan, who owned the Healthy Way Medical Center—a clinic offering beauty and cosmetic services—engaged in a scheme that exploited Medicare’s reimbursement system. The programme typically covers Botox injections when used to treat chronic migraines, but evidence presented in court showed that Mailyan falsely diagnosed patients and billed for exorbitant treatments while she was vacationing in locations such as Cabo, Maui, and Las Vegas.
Assistant Attorney General Colin M. McDonald commented on the case, criticising Mailyan’s actions as a “brazen scheme to rob Medicare.” He emphasised that her fraudulent activities were a betrayal to both patients and the public trust. This case exposes serious vulnerabilities in the Medicare system, highlighting the need for increased scrutiny in healthcare billing practices.

During the trial, it was revealed that Mailyan billed Medicare for thousands of Botox injections that were never administered. Alarmingly, some claims were filed for patients who were incarcerated and thus unable to receive treatments. Furthermore, she backdated claims, falsely asserting that injections had occurred before any contact with her clinic.
Mailyan’s fraudulent activities were not only limited to fabricated medical procedures; she also created bogus patient records, including consent forms that inaccurately represented her patients as suffering from chronic migraines. The court established that Mailyan reaped substantial financial gains from her deceit, using the illicitly acquired funds to finance extravagant holidays, indulge in collectible luxury items—including a £9,500 17th-century crossbow—and acquire costly artwork.
As a result of her conviction, the jury ordered the forfeiture of multiple assets connected to the fraudulent scheme. This includes two Tesla vehicles, amounts exceeding £200,000 across various bank accounts, brokerage accounts valued at over £6 million, and a cluster of four properties in California worth an estimated £6 million combined.
Mailyan’s practice drew the attention of investigators when data analytics from the Health Care Fraud Section flagged her as an “extreme outlier” in Medicare payments for Botox, having received over £19 million in an alarming four-year span—significantly more than her peers in the field.
She faces serious consequences for her misconduct, with sentencing scheduled for September 10, 2026. Mailyan could be looking at a maximum of 20 years in prison for each count of wire fraud, as well as five years for each count of obstruction—a hefty punishment reflecting the severity of her actions.
This case serves as a stark reminder of the potential for abuse within the healthcare system, particularly in sectors that involve significant government funding. The Justice Department’s commitment to tackling Medicare fraud through data-driven investigations underscores the ongoing effort to safeguard public trust and ensure accountability in medical practices. As the details of this case unfold, it reinforces the importance of vigilance in monitoring healthcare providers and protecting patients from exploitation.
